Matinas BioPharma Holdings, Inc. (MTNB) AI Dilution Summary

Estimated cash was $3,457,242 as of 2026-07-10, from $761,000 at 2026-06-30 against estimated monthly burn of $612,000. The most recent capital raised was $2,898,000 net across two events closed 2026-07-10: a Series D preferred private placement ($575,000 net) and a 2025 Warrants inducement cash exercise ($2,323,000 net). Dilution here is driven primarily by shelf capacity stated in dollars: $1,859,859 is currently available under I.B.6 on S-3 333-296813, which expires 2029-07-06.